Loading, Please Wait...
Innovative Robotic Surgical Platform Designed to Fully Optimize MIS Procedures
TORONTO, ON --(Marketwired - March 08, 2016) - Titan Medical, Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), today announced that it will make its first public unveiling and demonstration of its SPORT™ Surgical System at the upcoming Society of American Gastrointestinal and Endoscopic Surgeons Society (SAGES) 2016 Annual Meeting taking place March 16-19, 2016 in Boston, MA.
"We are excited to make the first public introduction and demonstration of our SPORT Surgical System at this important gathering of the surgical community," said John Hargrove, Chairman and CEO of Titan Medical Inc. "We developed the SPORT Surgical System to enable surgeons and hospital administrators to fully optimize the benefits of robotic surgeries, and its performance continues to exceed our expectations. In anticipation of regulatory approval, we have been building a strong and experienced team to support impending commercialization efforts and show the capabilities and significant benefits of this innovative and highly differentiated robotic surgical platform."
Titan's SPORT™ Surgical System comprises:
Titan Medical will exhibit at booth #501 and #600.
About SPORT™ Surgical System
On December 21, 2015, Titan announced the completion of the initial SPORT™ Surgical System for use in engineering verification to measure performance in relation to design specifications and to measure compliance with regulatory guidelines.
The SPORT™ Surgical System has been designed with the goal of providing the multi-articulating instruments and the 3D vision system for insertion into the patient's body cavity through a single incision of approximately 25mm. Once inserted, the device is configured to deploy into a working configuration wherein the 3D high definition vision system and multi-articulating instruments are capable of being controlled by a surgeon seated at the workstation.
The multi-articulating, interactive, snake-like instruments are designed to couple with removable and sterile single patient use robotic tools that would provide first use quality in every case and eliminate the reprocessing of the instrument. The use of reposable (re-usable for a specific number of uses) robotic instruments and single patient use tools allows more use cases for each robotic instrument thus reducing the per-case cost. The robotic platform is also designed to include a mast, a boom and wheels for optimal configurability for a variety of surgical indications and the ability to be maneuvered around the operating room and surgical centers where applicable.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's SPORT™ Surgical System, currently under development, includes a surgeon-controlled robotic platform that incorporates a 3D high-definition vision system and multi-articulating instruments for performing MIS procedures through a single incision. The surgical system also includes a surgeon workstation that provides a surgeon with an advanced ergonomic interface to the robotic platform for controlling the instruments and provides a 3D high-definition endoscopic view of inside a patient's body. The SPORT™ Surgical System is designed to enable surgeons to perform a broad set of surgical procedures for general abdominal, gynecologic, and urologic indications. For more information, visit the Company's website at www.titanmedicalinc.com.
This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors " section of the Company's Annual Information Form dated March 31, 2015 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.
Titan Medical Inc.
Chief Executive Officer
(416) 548-7522 (ext. 151)
EVC Group, Inc.